- Home
- DRIO vs PULM Comparison
DRIO vs PULM Comparison
Compare DRIO & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- PULM
- Stock Information
- Founded
- DRIO 2011
- PULM 2003
- Country
- DRIO United States
- PULM United States
- Employees
- DRIO N/A
- PULM N/A
- Industry
- DRIO Medical/Dental Instruments
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- DRIO Health Care
- PULM Health Care
- Exchange
- DRIO Nasdaq
- PULM Nasdaq
- Market Cap
- DRIO 28.3M
- PULM 30.9M
- IPO Year
- DRIO N/A
- PULM N/A
- Fundamental
- Price
- DRIO $0.66
- PULM $6.12
- Analyst Decision
- DRIO Strong Buy
- PULM
- Analyst Count
- DRIO 1
- PULM 0
- Target Price
- DRIO $2.00
- PULM N/A
- AVG Volume (30 Days)
- DRIO 199.1K
- PULM 9.0K
- Earning Date
- DRIO 05-14-2025
- PULM 05-27-2025
- Dividend Yield
- DRIO N/A
- PULM N/A
- EPS Growth
- DRIO N/A
- PULM N/A
- EPS
- DRIO N/A
- PULM N/A
- Revenue
- DRIO $28,034,000.00
- PULM $7,806,000.00
- Revenue This Year
- DRIO $22.41
- PULM N/A
- Revenue Next Year
- DRIO $19.97
- PULM $134.88
- P/E Ratio
- DRIO N/A
- PULM N/A
- Revenue Growth
- DRIO 32.86
- PULM 6.96
- 52 Week Low
- DRIO $0.50
- PULM $1.72
- 52 Week High
- DRIO $1.93
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- DRIO 43.91
- PULM 45.47
- Support Level
- DRIO $0.68
- PULM $5.98
- Resistance Level
- DRIO $0.78
- PULM $6.68
- Average True Range (ATR)
- DRIO 0.06
- PULM 0.34
- MACD
- DRIO -0.01
- PULM 0.01
- Stochastic Oscillator
- DRIO 12.63
- PULM 24.74
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.